glp 1 medications after bariatric surgery GLP-1 safe to continue before in patients with diabetes and obesity GLP-1 medications and bariatric surgery

Explore 23andMes new GLP-1 service and the revenue potential of compounded medications, plus key risks and industry insights.

The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.

(For a detailed history, I recommend Megan Molteni and Elaine Chens piece for STAT.) The benefits of these drugs are undeniable, but when it comes to evaluating their risks, we run into challenges that researchers are familiar with but that the public at large may not be aware of

Long-format design accommodates the taller vial profile used by many GLP-1 and compounded peptide medications

30 individually packaged sticks for convenient use

People are losing 15, 20 percent of their body weight